Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Browse the detailed record of transactions filed by Sofiane FAHMY. Director active across 1 company, notably Swedish Orphan Biovitrum AB (publ). In total, 7 disclosures have been recorded. History available since 10 June 2025. The latest transaction was disclosed on 12 June 2026 (Purchase). Regulator: FIN-FSA. The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations
Sofiane FAHMY is a declarant linked to Swedish Orphan Biovitrum AB (publ) as Annan ledande befattningshavare. Across 5 filings in total, the 5 sampled filings cover the period from 2026-05-12 to 2026-06-16 and show EUR 2384849 of purchases and EUR 5087765 of sales.